HOME >> BIOLOGY >> NEWS
Asthma-linked genes discovered at Berkeley lab

BERKELEY, CA - Researchers at the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) have announced the discovery of two genes that contribute to the development of asthma. The finding suggests that decreasing the activity of these two genes could help reduce susceptibility to asthma attacks.

A team led by Dr. Edward Rubin and Derek Symula of Berkeley Lab's Life Sciences Division, and including scientists from the University of California, San Francisco campus, worked with transgenic mice (mice that carry human genes) and found that even subtle changes in the activity of the interleukin genes IL4 and IL13 can have an important effect on asthma susceptibility. Their research results were reported in the October 1 issue of the journal Nature Genetics.

More than 14 million people in the United States suffer from asthma and other chronic respiratory ailments. The number of victims has doubled over the last 15 years and is still on the rise, with children living in urban areas particularly susceptible. Medical researchers have no explanation for this upsurge but it is approaching epidemic stature.

"Thousands of years ago the ancient Greeks observed that asthma ran in families," says Symula, a post-doctoral fellow who joined Rubin's research group nearly four years ago to begin an intensive hunt to identify the genetic factors. "What we knew, at the outset of our studies, was that one region of the human genome, on chromosome 5, tended to be inherited in individuals with asthma."

Rubin's group has previously developed mouse models from a variety of human conditions including Down syndrome, sickle cell disease, and atherosclerosis. For the asthma study, they eschewed the conventional approach for identifying genetic links to a specific disease.

Explains Rubin, "Rather than looking at one gene at a time, we chose to simultaneously examine several genes in parallel, by introducing 8-10 human genes at a time into
'"/>

Contact: David Gilbert
degilbert@lbl.gov
510-486-6096
DOE/Lawrence Berkeley National Laboratory
4-Oct-1999


Page: 1 2 3

Related biology news :

1. Belgian researchers explore revolutionary approach to angiogenesis
2. Tracing genes, biologists show lizard migration is traced to Florida
3. Certain genes boost fish oils protection against breast cancer
4. Fossil genes reveal how life sheds form and function
5. Missing genes may help explain why plague bacteria are so deadly
6. Do genes respond to global warming?
7. Genetic map of important tree genes outlined
8. Mitochondrial genes cause nuclear mischief
9. Identifying tick genes could halt disease, bioterrorism threat
10. A genetic disorder yields insight into genes and cognition
11. Mouse study shows NPAS3 and NPAS1 genes may be linked to psychosis

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Asthma linked genes discovered Berkeley lab

(Date:10/16/2014)... tract infections and worldwide claims the lives of ... Ghent University have succeeded in developing a promising ... , Xavier Saelens (VIB/UGent): "We discovered a ... the development of a novel approach to vaccination ... numerous small children and elderly people." , ...
(Date:10/15/2014)... ,Models of Life, is a non-traditional biophysics textbook and ... book is a journey of discovery into biological systems ... and biological regulation. It is about how our genes ... between the billions of cells in an organism. It ... between principles, which can be found on both large ...
(Date:10/15/2014)... awarded the 44th Rosenstiel Award for Distinguished Work in ... exploring the mechanisms of genomic instability and its implications ... the second alumnus to win the Rosenstiel Award; the ... , Alt is the Charles A. Janeway Professor of ... and an investigator at the Howard Hughes Medical Institute ...
Breaking Biology News(10 mins):New perspectives for development of an RSV vaccine 2New book about life as seen from physics 2Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2
(Date:10/22/2014)... October 21, 2014 The North American ... market North America with analysis and forecast of revenue. ... and is expected to reach $623.6 million by 2018, ... , Browse through the TOC of the North American ... the in-depth analysis provided. This also provides a glimpse ...
(Date:10/22/2014)... Diego, CA (PRWEB) October 22, 2014 ... balances from Sartorius, A & D Weighing, Rice ... Sartorius CPA Semi-Micro Balance . The Sartorius CPA ... for an affordable high-quality, precise, and user-friendly laboratory ... manufacturing of laboratory equipment, their laboratory balances are ...
(Date:10/22/2014)... --  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... and diseases, announced today that the U.S. Patent and ... a composition of matter patent application that covers the ... This is Synthetic Biologics, first allowed patent application directly ... the Company,s extensive C. difficile patent estate. ...
(Date:10/22/2014)... HONG KONG , Oct. 22, 2014 ... enterprise, announced today that rare disease expert John ... president, research. Dr. McKew brings more than two decades ... at the National Institutes of Health, Wyeth Research and ... McKew will lead aTyr,s efforts to expand and translate ...
Breaking Biology Technology:The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 2The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 3The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 4Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 2Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3
Cached News: